# Biolipox

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biolipox

- Industry: Pharmaceuticals
- Headquarters: Sweden
- Total disclosed funding: $27M
- Latest round: Series B (Jan 22, 2003)
- Investors on record: 5

## About

Biolipox AB is a Sweden-based company that operates as a provider of pharmaceuticals for the treatment of respiratory and other inflammatory diseases.

## Funding rounds

- Series B, Jan 22, 2003, $22M — Apax Partners, Auriga Partners, Sofinnova Partners, HealthCap, Omnes Capital
- Series A, Mar 1, 2001, $4.2M — Sofinnova Partners, HealthCap
- Seed, Jun 1, 2000, $0.5M — HealthCap

## Investors

- HealthCap — Seed, Series A, Series B
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A, Series B
- Apax Partners (https://capitalatlas.ai/funds/apax-partners) — Series B
- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series B
- Omnes Capital (https://capitalatlas.ai/funds/omnes-capital) — Series B